Apoptosis signal regulating kinase 1 deletion mitigates α-synuclein pre-formed fibril propagation in mice

Alvarez-Erviti, 2011, Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line, Neurosci. Res., 69, 337, 10.1016/j.neures.2010.12.020 Anderson, 2006, Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease, J. Biol. Chem., 281, 29739, 10.1074/jbc.M600933200 Beraud, 2012, Misfolded alpha-synuclein and Toll-like receptors: therapeutic targets for Parkinson's disease, Parkinsonism Relat. Disord., 18, S17, 10.1016/S1353-8020(11)70008-6 Blandini, 2010, An update on the potential role of excitotoxicity in the pathogenesis of Parkinson's disease, Funct. Neurol., 25, 65 Blumenstock, 2017, Seeding and transgenic overexpression of alpha-synuclein triggers dendritic spine pathology in the neocortex, EMBO Mol. Med., 9, 716, 10.15252/emmm.201607305 Boza-Serrano, 2014, The role of Galectin-3 in alpha-synuclein-induced microglial activation, Acta Neuropathol. Commun., 2, 156 Braak, 2017, Neuropathological staging of brain pathology in sporadic Parkinson's disease: separating the wheat from the chaff, J. Parkinsons Dis., 7, S71, 10.3233/JPD-179001 Cornejo Castro, 2010, Parkinson's disease-associated DJ-1 modulates innate immunity signaling in Caenorhabditis elegans, J. Neural Transm. (Vienna), 117, 599, 10.1007/s00702-010-0397-4 Deacon, 2006, Assessing nest building in mice, Nat. Protoc., 1, 1117, 10.1038/nprot.2006.170 Dias, 2013, The role of oxidative stress in Parkinson's disease, J. Parkinsons Dis., 3, 461, 10.3233/JPD-130230 Dickson, 2009, Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria, Lancet Neurol., 8, 1150, 10.1016/S1474-4422(09)70238-8 Dryanovski, 2013, Calcium entry and alpha-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons, J. Neurosci., 33, 10154, 10.1523/JNEUROSCI.5311-12.2013 Freundt, 2012, Neuron-to-neuron transmission of α-synuclein fibrils through axonal transport, Ann. Neurol., 72, 517, 10.1002/ana.23747 Fujiwara, 2002, Alpha-synuclein is phosphorylated in synucleinopathy lesions, Nat. Cell Biol., 4, 160, 10.1038/ncb748 Gao, 2011, Neuroinflammation and alpha-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease, Environ. Health Perspect., 119, 807, 10.1289/ehp.1003013 Glass, 2010, Mechanisms underlying inflammation in neurodegeneration, Cell, 140, 918, 10.1016/j.cell.2010.02.016 Goedert, 2001, Alpha-synuclein and neurodegenerative diseases, Nat. Rev. Neurosci., 2, 492, 10.1038/35081564 Goodwin, 2013, Raised calcium and oxidative stress cooperatively promote alpha-synuclein aggregate formation, Neurochem. Int., 62, 703, 10.1016/j.neuint.2012.11.004 Grassi, 2018, Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson’s disease, Proc. Natl. Acad. Sci. U. S. A., 115, E2634, 10.1073/pnas.1713849115 Grosso, 2014, Transglutaminase 2 exacerbates alpha-synuclein toxicity in mice and yeast, FASEB J., 28, 4280, 10.1096/fj.14-251413 Halliday, 2011, Glia: initiators and progressors of pathology in Parkinson's disease, Mov. Disord., 26, 6, 10.1002/mds.23455 Hu, 2011, Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade, J. Neurosci., 31, 247, 10.1523/JNEUROSCI.4589-10.2011 Hwang, 2013, Role of oxidative stress in Parkinson's disease, Exp. Neurobiol., 22, 11, 10.5607/en.2013.22.1.11 Ichijo, 1997, Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways, Science, 275, 90, 10.1126/science.275.5296.90 Jiang, 2007, Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death, Neurobiol. Aging, 28, 1709, 10.1016/j.neurobiolaging.2006.07.017 Junn, 2002, Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine, Neurosci. Lett., 320, 146, 10.1016/S0304-3940(02)00016-2 Kim, 2009, Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP, J. Neurochem., 109, 1483, 10.1111/j.1471-4159.2009.06075.x Langston, 1999, Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure, Ann. Neurol., 46, 598, 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F Lee, 2010, Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1, J. Immunol., 185, 615, 10.4049/jimmunol.0903480 Lee, 2014, Extracellular alpha-synuclein—a novel and crucial factor in Lewy body diseases, Nat. Rev. Neurol., 10, 92, 10.1038/nrneurol.2013.275 Lee, 2015, Apoptosis signal-regulating kinase 1 modulates the phenotype of alpha-synuclein transgenic mice, Neurobiol. Aging, 36, 519, 10.1016/j.neurobiolaging.2014.07.034 Lee, 2012, Apoptosis signal-regulating kinase 1 mediates MPTP toxicity and regulates glial activation, PLoS One, 7, e29935, 10.1371/journal.pone.0029935 Lovering, 2018, Rational approach to highly potent and selective apoptosis signal-regulating kinase 1 (ASK1) inhibitors, Eur. J. Med. Chem., 145, 606, 10.1016/j.ejmech.2017.12.041 Luk, 2012, Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice, Science, 338, 949, 10.1126/science.1227157 Ma, 2003, Alpha-synuclein aggregation and neurodegenerative diseases, J. Alzheimers Dis., 5, 139, 10.3233/JAD-2003-5208 Masuda-Suzukake, 2014, Pathological alpha-synuclein propagates through neural networks, Acta Neuropathol. Commun., 2, 88, 10.1186/s40478-014-0088-8 Nishitoh, 2002, ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats, Genes Dev., 16, 1345, 10.1101/gad.992302 Oueslati, 2016, Implication of alpha-synuclein phosphorylation at S129 in synucleinopathies: what have we learned in the last decade?, J. Parkinsons Dis., 6, 39, 10.3233/JPD-160779 Paumier, 2015, Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration, Neurobiol. Dis., 82, 185, 10.1016/j.nbd.2015.06.003 Sacino, 2014, Brain injection of alpha-synuclein induces multiple proteinopathies, gliosis, and a neuronal injury marker, J. Neurosci., 34, 12368, 10.1523/JNEUROSCI.2102-14.2014 Saijo, 2011, Microglial cell origin and phenotypes in health and disease, Nat. Rev. Immunol., 11, 775, 10.1038/nri3086 Saitoh, 1998, Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1, EMBO J., 17, 2596, 10.1093/emboj/17.9.2596 Sedelis, 2000, MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences, Behav. Genet., 30, 171, 10.1023/A:1001958023096 Song, 2002, Role of glutaredoxin in metabolic oxidative stress. Glutaredoxin as a sensor of oxidative stress mediated by H2O2, J. Biol. Chem., 277, 46566, 10.1074/jbc.M206826200 Spillantini, 1998, Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies, Proc. Natl. Acad. Sci. U. S. A., 95, 6469, 10.1073/pnas.95.11.6469 Thakur, 2017, Modeling Parkinson's disease pathology by combination of fibril seeds and alpha-synuclein overexpression in the rat brain, Proc. Natl. Acad. Sci. U. S. A., 114, E8284, 10.1073/pnas.1710442114 Tobiume, 2001, ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis, EMBO Rep., 2, 222, 10.1093/embo-reports/kve046 Tobiume, 2002, Activation of apoptosis signal-regulating kinase 1 by the stress-induced activating phosphorylation of pre-formed oligomer, J. Cell Physiol, 191, 95, 10.1002/jcp.10080 Turnbull, 2001, Alpha-synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro, Free Radic. Biol. Med., 30, 1163, 10.1016/S0891-5849(01)00513-5 Ulusoy, 2015, Neuron-to-neuron α-synuclein propagation in vivo is independent of neuronal injury, Acta Neuropathol. Commun., 3, 13, 10.1186/s40478-015-0198-y Valente, 2012, Molecular pathways in sporadic PD, Parkinsonism Relat. Disord., 18, S71, 10.1016/S1353-8020(11)70023-2 Volpicelli-Daley, 2011, Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death, Neuron, 72, 57, 10.1016/j.neuron.2011.08.033 Weinreb, 1996, NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded, Biochemistry, 35, 13709, 10.1021/bi961799n Wilms, 2009, Suppression of MAP kinases inhibits microglial activation and attenuates neuronal cell death induced by alpha-synuclein protofibrils, Int. J. Immunopathol Pharmacol., 22, 897, 10.1177/039463200902200405 Wu, 2008, Characterization of conformational and dynamic properties of natively unfolded human and mouse alpha-synuclein ensembles by NMR: implication for aggregation, J. Mol. Biol., 378, 1104, 10.1016/j.jmb.2008.03.017 Yan, 2018, Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB, Proc. Natl. Acad. Sci. U. S. A., 115, E12053, 10.1073/pnas.1813365115 Zhang, 2005, Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease, FASEB J., 19, 533, 10.1096/fj.04-2751com